SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-155359
Filing Date
2018-05-08
Accepted
2018-05-08 09:01:51
Documents
47
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d570377d10q.htm 10-Q 519583
2 EX-31.1 d570377dex311.htm EX-31.1 9056
3 EX-31.2 d570377dex312.htm EX-31.2 9036
4 EX-32.1 d570377dex321.htm EX-32.1 5137
  Complete submission text file 0001193125-18-155359.txt   2054823

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aqxp-20180331.xml EX-101.INS 274512
6 XBRL TAXONOMY EXTENSION SCHEMA aqxp-20180331.xsd EX-101.SCH 24741
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqxp-20180331_cal.xml EX-101.CAL 35300
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqxp-20180331_def.xml EX-101.DEF 59163
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqxp-20180331_lab.xml EX-101.LAB 205012
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqxp-20180331_pre.xml EX-101.PRE 140821
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 18813142
SIC: 2834 Pharmaceutical Preparations